Cargando…
BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia
Approximately 30% of the patients who fulfil the criteria of Waldenström's macroglobulinemia (WM) are diagnosed while asymptomatic (indolent), and will not require immediate therapy. Conversely, patients with a disease-related event will be considered for therapy. The physiopathology of these 2...
Autores principales: | Herbaux, Charles, Bertrand, Elisabeth, Marot, Guillemette, Roumier, Christophe, Poret, Nicolas, Soenen, Valérie, Nibourel, Olivier, Roche-Lestienne, Catherine, Broucqsault, Natacha, Galiègue-Zouitina, Sylvie, Boyle, Eileen M, Fouquet, Guillemette, Renneville, Aline, Tricot, Sabine, Morschhauser, Franck, Preudhomme, Claude, Quesnel, Bruno, Poulain, Stephanie, Leleu, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593656/ https://www.ncbi.nlm.nih.gov/pubmed/28924457 http://dx.doi.org/10.18632/oncotarget.9917 |
Ejemplares similares
-
Role of IRF4 in resistance to immunomodulatory (IMid) compounds(®) in Waldenström’s macroglobulinemia
por: Bertrand, Elisabeth, et al.
Publicado: (2017) -
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
por: Dogliotti, Irene, et al.
Publicado: (2022) -
Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013) -
Waldenstrom’s Macroglobulinemia: An Update
por: Mazzucchelli, Maddalena, et al.
Publicado: (2018) -
Waldenstrom's macroglobulinemia associated with eosinophilia
por: You, Eunkyoung, et al.
Publicado: (2013)